A BChE inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NSC 620023 (trifluoroacetate salt)

Item No. 401037

Product Insert (PDF)
Technical Information
Formal Name
2,6-bis[[[2-(1H-benzimidazol-2-yl)ethyl]thio]methyl]-4-methyl-phenol, trifluoroacetate salt
Molecular Formula
C27H28N4OS2 • 2CF3COOH
Formula Weight
716.7
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Sparingly soluble: 1-10 mg/ml
SMILES
OC1=C(CSCCC2=NC3=C(C=CC=C3)N2)C=C(C)C=C1CSCCC4=NC5=C(N4)C=CC=C5.OC(C(F)(F)F)=O.OC(C(F)(F)F)=O
InChi Code
InChI=1S/C27H28N4OS2.2C2HF3O2/c1-18-14-19(16-33-12-10-25-28-21-6-2-3-7-22(21)29-25)27(32)20(15-18)17-34-13-11-26-30-23-8-4-5-9-24(23)31-26;2*3-2(4,5)1(6)7/h2-9,14-15,32H,10-13,16-17H2,1H3,(H,28,29)(H,30,31);2*(H,6,7)
InChi Key
CSDCFZXLIIVSRU-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $39

    Add

    5 mg

    $174

    Add
    Product Description

    NSC 620023 is an inhibitor of butyrylcholinesterase (BChE; IC50 = 40 nM).1 It is selective for BChE over acetylcholinesterase (AChE; IC50 = 2,604 nM).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Williams, A., Zhou, S., and Zhan, C.G. Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening. Bioorg. Med. Chem. Lett. 29(24), 126754 (2019).